fbpx Back to Top


Get Help with Your Treatment

Apply Online or call 1-866-316-7263


Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.


For current information, log in to FundFinder.

Assistance Amount

$2,300 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for neutropenia.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product.
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 400% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Fulphila (pegfilgrastim-jmdb)
  • Granix (tbo-filgrastim)
  • Leukine (sargramostim)
  • Mozobil (plerixafor)
  • Neulasta (pegfilgrastim)
  • Neupogen (filgrastim)
  • Nivestym (filgrastim-aafi)
  • Udenyca (pegfilgrastim-cbqv)
  • Zarxio (filgrastim-sndz)
  • Ziextenzo (pegfilgrastim-bmez)

Diagnosis Codes:

ICD-10: D70.0, D70.1, D70.2, D70.3, D70.4, D70.8, D70.9, D70.0, D70.1, D70.2, D70.3, D70.4, D70.8, D70.9


About the Disease:

Neutropenia, also known as chemotherapy-induced neutropenia, is a disorder caused by certain cancer treatments associated with an abnormally low level of neutrophils, a type of white blood cell. It affects the circulatory system.


Source: National Institutes of Health

Related Organizations: